Chemomab Therapeutics (2QV) Earnings Dates, Call Summary & Reports
Earnings Data
- Estimated Report Date
- Nov 06, 2026
- Period Ending
- 2026 (Q3)
- Consensus EPS Forecast
- 0.00
- Last Year’s EPS
- -0.01
TBA (Not Confirmed)
Same Quarter Last Year
Chemomab Therapeutics (DE:2QV) Earnings, Revenues Date & History
The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced.
DE:2QV Q2 2026 Earnings Report
DE:2QV Upcoming Earnings
Chemomab Therapeutics's next earnings date is estimated for November 6, 2026, based on past reporting schedules.
DE:2QV Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release | Slides | Play Transcript |
|---|---|---|---|---|---|---|---|
| Nov 06, 2026 | 2026 (Q3) | 0.00- | -0.01 | ― | ― | ― | ― |
| Aug 19, 2026 | 2026 (Q2) | -0.13-0.00 | -0.01 | 81.25% (+0.01) | ― | ― | |
| May 14, 2026 | 2026 (Q1) | 0.00-0.00 | -0.03 | 89.29% (+0.02) | ― | ― | |
| Mar 19, 2026 | 2025 (Q4) | -0.04-0.00 | -0.03 | 90.63% (+0.03) | ― | ― | |
| Nov 20, 2025 | 2025 (Q3) | -0.04-0.01 | -0.04 | 60.00% (+0.02) | ― | ― | |
| Aug 14, 2025 | 2025 (Q2) | -0.04-0.01 | -0.05 | 69.23% (+0.03) | ― | ― | |
| May 15, 2025 | 2025 (Q1) | -0.04-0.03 | -0.05 | 50.00% (+0.03) | ― | ― | |
| Mar 03, 2025 | 2024 (Q4) | -0.04-0.03 | -0.05 | 38.46% (+0.02) | ― | ― | |
| Nov 14, 2024 | 2024 (Q3) | -0.04-0.04 | -0.06 | 41.18% (+0.03) | ― | ― | |
| Aug 21, 2024 | 2024 (Q2) | -0.04-0.05 | -0.13 | 63.89% (+0.08) | ― | ― |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous quarter.
Beat Missed
DE:2QV Earnings-Related Price Changes
| Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Aug 19, 2026 | €2.94 | €2.94 | +0.00% |
| May 14, 2026 | €2.94 | €2.94 | +0.00% |
| Mar 19, 2026 | €2.94 | €2.94 | +0.00% |
| Nov 20, 2025 | €2.94 | €2.94 | +0.00% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after its recent earnings reports.
FAQ
When does Chemomab Therapeutics (DE:2QV) report earnings?
Chemomab Therapeutics (DE:2QV) is estimated to report earnings on Nov 06, 2026, TBA (Not Confirmed). The date is an estimate based on past reporting schedules and may change.
What is DE:2QV EPS forecast?
DE:2QV EPS forecast for the fiscal quarter 2026 (Q3) is 0.00.
